HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preventive effects of a mixed disulphide from dithiocarbamate and N-acetylcysteine on the genotoxicity of N-nitrosodiethylamine.

Abstract
A mixed disulphide model compound, S-(N,N-diethyldithiocarbamoyl)-N-acetylcysteine (AC-DDTC), prepared from diethyldithiocarbamate and N-acetylcysteine, was investigated for protective effects against the genotoxicity of the environmental carcinogen N-nitrosodiethylamine (NDEA). AC-DDTC was found to be a potent inhibitor of genotoxicity induced by NDEA. The mutagenicity of NDEA to Salmonella typhimurium was inhibited by 70% at 3.2 micromol AC-DDTC per plate and the effect was dose-dependent. In the chromosome aberration assay, NDEA elicited a significant increase in the number of aberrant cells. Pretreatment with AC-DDTC suppressed the chromosome-damaging effect of NDEA. The micronucleus-inducing capacity of NDEA was reduced by 32% by treatment with AC-DDTC at 1.5 mmol kg(-1). These results suggest that AC-DDTC might have a role to play in reducing the risk of cancer induced by NDEA.
AuthorsB H Lee, S J Lee
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 51 Issue 1 Pg. 105-9 (Jan 1999) ISSN: 0022-3573 [Print] England
PMID10197426 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimutagenic Agents
  • Mutagens
  • S-(N,N-diethyldithiocarbamoyl)-N-acetylcysteine
  • Diethylnitrosamine
  • Acetylcysteine
Topics
  • Acetylcysteine (analogs & derivatives, pharmacology)
  • Animals
  • Antimutagenic Agents (pharmacology)
  • Chromosome Aberrations (genetics)
  • Cricetinae
  • Cricetulus
  • Diethylnitrosamine (toxicity)
  • Drug Interactions
  • Male
  • Mice
  • Mice, Inbred ICR
  • Micronucleus Tests
  • Mutagenicity Tests
  • Mutagens (toxicity)
  • Salmonella typhimurium (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: